Akoya to Participate at Two Upcoming Investor Conferences

MARLBOROUGH, Mass., June 12, 2023 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company^®, today announced that Company management will be participating in two upcoming investor conferences.

• Capital One Securities 2^nd Annual Spatial Biology and Proteomics Virtual Research Summit
  “Pushing the Envelope of Technology with Increased Sensitivity and Higher Plex on the Horizon” Panel on Tuesday, June 20^th at 10:30 AM ET
  Niro Ramachandran, CBO

• TD Cowen 2^nd Annual Tools/Dx Revolution
  “Spatial – The Next Frontier: Clinical” Panel on Monday, June 26^th at 4:20 PM PT
  Brian McKelligon, CEO

A live and archived webcast of the Capital One event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.

About Akoya Biosciences
As The Spatial Biology Company^®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.

Investor Contact:
Priyam Shah
Sr. Director, Investor Relations
Akoya Biosciences, Inc.
investors@akoyabio.com

Media Contact:
Christine Quern
(617) 650-8497
media@akoyabio.com